Literature DB >> 32802579

Evaluation of dose distribution differences from five algorithms implemented in three commercial treatment planning systems for lung SBRT.

Vikren Sarkar1, Adam Paxton1, Prema Rassiah1, Kristine E Kokeny1, Ying J Hitchcock1, Bill J Salter1.   

Abstract

Early stage lung cancer is increasingly being treated using stereotactic body radiation therapy (SBRT). Several advanced treatment planning algorithms are now available in various commercial treatment planning systems. This work compares the dose distributions calculated for the same treatment plan using, five algorithms, in three different treatment planning systems. All plans were normalized to ensure the prescription dose covers 95% of the planning target volume (PTV). Dose to the planning target volume (PTV) was compared using near-minimum dose (D98%), near-maximum dose (D2%) and dose homogeneity, while dose fall-off was compared using D2cm and R50. Dose to the lung was compared using V5Gy, V20Gy and mean lung dose. Statistical analysis shows that dose distributions calculated using Eclipse's Acuros XB and RayStation's Monte Carlo were significantly different from the other dose distributions for the PTV dose parameters investigated. For lung dosimetric parameters, this difference persisted for volumetric modulated arc therapy (VMAT) plans but not for conformal arc plans. While normal tissue complication probability (NTCP) differences were significant for some of the algorithms for VMAT delivery approaches, they were not significantly different for any algorithm for conformal arc plans. All parameters investigated here were within 5% between all algorithms. The results show that, while some small dosimetric differences can be expected around the PTV, the dose distribution to the rest of the treatment area, especially the lungs, should not be clinically-relevant when switching between one of the five algorithms investigated.
© 2020 Old City Publishing, Inc.

Entities:  

Keywords:  Treatment planning; algorithms; lung SBRT

Year:  2020        PMID: 32802579      PMCID: PMC7406340     

Source DB:  PubMed          Journal:  J Radiosurg SBRT


  21 in total

1.  CERR: a computational environment for radiotherapy research.

Authors:  Joseph O Deasy; Angel I Blanco; Vanessa H Clark
Journal:  Med Phys       Date:  2003-05       Impact factor: 4.071

2.  Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Authors:  Frank J Lagerwaard; Naomi E Verstegen; Cornelis J A Haasbeek; Ben J Slotman; Marinus A Paul; Egbert F Smit; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-19       Impact factor: 7.038

3.  Dosimetric comparison of Acuros XB deterministic radiation transport method with Monte Carlo and model-based convolution methods in heterogeneous media.

Authors:  Tao Han; Justin K Mikell; Mohammad Salehpour; Firas Mourtada
Journal:  Med Phys       Date:  2011-05       Impact factor: 4.071

4.  Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.

Authors:  Yvette Seppenwoolde; Joos V Lebesque; Katrien de Jaeger; José S A Belderbos; Liesbeth J Boersma; Cees Schilstra; George T Henning; James A Hayman; Mary K Martel; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

5.  Dosimetric comparison of Acuros XB, AAA, and XVMC in stereotactic body radiotherapy for lung cancer.

Authors:  Yusuke Tsuruta; Manabu Nakata; Mitsuhiro Nakamura; Yukinori Matsuo; Kyoji Higashimura; Hajime Monzen; Takashi Mizowaki; Masahiro Hiraoka
Journal:  Med Phys       Date:  2014-08       Impact factor: 4.071

6.  Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer--report on clinical outcome and dose to critical organs.

Authors:  Alice W Y Ng; Stewart Y Tung; Victy Y W Wong
Journal:  Radiother Oncol       Date:  2008-03-10       Impact factor: 6.280

7.  Monte Carlo calculation of dose distribution in early stage NSCLC patients planned for accelerated hypofractionated radiation therapy in the NCIC-BR25 protocol.

Authors:  V Moiseenko; M Liu; A M Bergman; B Gill; S Kristensen; T Teke; I A Popescu
Journal:  Phys Med Biol       Date:  2010-01-13       Impact factor: 3.609

8.  The North American experience with stereotactic body radiation therapy in non-small cell lung cancer.

Authors:  Robert D Timmerman; Clint Park; Brian D Kavanagh
Journal:  J Thorac Oncol       Date:  2007-07       Impact factor: 15.609

9.  Dosimetric accuracy and clinical quality of Acuros XB and AAA dose calculation algorithm for stereotactic and conventional lung volumetric modulated arc therapy plans.

Authors:  Petra S Kroon; Sandra Hol; Marion Essers
Journal:  Radiat Oncol       Date:  2013-06-24       Impact factor: 3.481

10.  Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.

Authors:  X Liang; J Penagaricano; D Zheng; S Morrill; X Zhang; P Corry; R J Griffin; E Y Han; M Hardee; V Ratanatharathom
Journal:  Radiat Oncol       Date:  2016-01-22       Impact factor: 3.481

View more
  1 in total

1.  Dosimetric Impact of Acuros XB Dose-to-Water and Dose-to-Medium Reporting Modes on Lung Stereotactic Body Radiation Therapy and Its Dependency on Structure Composition.

Authors:  Carles Muñoz-Montplet; Rafael Fuentes-Raspall; Diego Jurado-Bruggeman; Sebastià Agramunt-Chaler; Albert Onsès-Segarra; Maria Buxó
Journal:  Adv Radiat Oncol       Date:  2021-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.